QbD Group
QbD Group is a privately held Belgian life sciences consulting firm with 700+ in-house specialists across 11+ European offices, delivering regulatory affairs, clinical, quality assurance, validation, and software services to pharma, biotech, medical device, and IVD companies worldwide.
- Company typePrivate
- Founded2011
- HeadquartersWilrijk, Belgium
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What QbD Group does
QbD Group is a privately held Belgian life sciences consulting firm founded in 2011 by Bart Van Acker, headquartered in Wilrijk (Antwerp) and operating 11+ offices across Belgium, the Netherlands, Spain, Poland, the UK, Switzerland, Austria, Colombia, and the US with 700+ in-house professionals. The firm delivers integrated regulatory affairs, clinical trial, qualification and validation, quality assurance, software solutions, pharmacovigilance, toxicology, and audit services to pharmaceutical, biotechnology, medical device, IVD, companion diagnostics, combination product, and medical device software companies across the full lifecycle from idea to patient. The firm operates a multi-subsidiary structure including QbD IVD | Qarad (IVD regulatory affairs), Quercus (GMP-certified contract lab), Scilife (SaaS quality management platform), Simabs (CDMO for monoclonal antibodies), SciencePharma (Polish pharma consulting), and Rescop (computer system validation).
The firm's business model is overwhelmingly professional services and project-based consulting, complemented by SaaS subscription revenue through Scilife and CDMO income from Simabs. Go-to-market is enterprise field sales delivered through 11+ regional offices, with a particular emphasis on positioning the firm as a "gateway to the EU" for non-EU life sciences clients needing MDR/IVDR compliance and market entry support. Pricing is quote-driven with no public rate cards, and the firm holds ISO 13485:2016, ISO/IEC 27001:2022, and GMP certifications as credibility markers. Demand generation is content-led through a knowledge center of 509+ resources, industry event presence (CPHI, Medica, TOPRA, ESMO), and seven consecutive years of Deloitte Platinum Best Managed Company recognition. Technology is centered on the Scilife SaaS QMS platform, with AI capabilities positioned primarily through partnerships (FormlyAI, Timeseer, Vigintake, delaware) rather than proprietary models.
QbD Group firmographics
Firmographics- Name
- QbD Group
- Legal name
- QbD Group
- Website
- https://qbdgroup.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- QbD Group is a privately held Belgian life sciences consulting firm with 700+ in-house specialists across 11+ European offices, delivering regulatory affairs, clinical, quality assurance, validation, and software services to pharma, biotech, medical device, and IVD companies worldwide.
- Ownership category
- akta.pro rank
QbD Group industry classification
Industry- Product category
- Life Sciences Regulatory Consulting
- NAICS
- Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- CMC Regulatory Affairs (Modules 2/3, Variations, Post-Approval CMC) (HLAGAKAB)
- akta.pro secondary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where QbD Group is headquartered
LocationHeadquarters
- HQ city
- Wilrijk
- HQ country
- Belgium
- HQ region
- Europe
Offices10 records
Markets served
QbD Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Professional Services: Consulting and advisory services in regulatory affairs, clinical trials, qualification and validation, quality assurance, software services, and market entry strategies for Pharma, Biotech, Medical Devices, and IVD industries. Revenue generated through project-based consulting engagements, audits, and specialized services.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
QbD Group product offering
Product offeringCore offering
QbD Group is a life sciences consulting firm that delivers full-lifecycle support from idea to patient across Pharma, Biotech, Medical Devices, and IVD industries. The company sells professional services in Regulatory Affairs, Clinical Solutions, Qualification & Validation, Quality Assurance, Software Solutions & Services, Toxicology, Lab Services, Pharmacovigilance, Audits, and Companion Diagnostics, complemented by the Scilife SaaS quality management platform and the GMP-certified Quercus contract laboratory.
Product overview
QbD Group is a life sciences consulting firm offering a comprehensive ecosystem of services and subsidiary companies. The core offering includes consulting services across Regulatory Affairs, Clinical Solutions, Qualification & Validation, Quality Assurance, Software Solutions & Services, Toxicology, Lab Services, and Pharmacovigilance. The group operates several subsidiary companies: QbD IVD | Qarad (IVD regulatory affairs and QA, 35 years expertise), Quercus (GMP certified contract laboratory), Scilife (SaaS quality management platform), Simabs (monoclonal antibody CDMO), SciencePharma (Polish pharma consulting), and Rescop (computer system validation). Services span Pharma & Biotech, Medical Devices, In Vitro Diagnostics, Companion Diagnostics, and Combination Products industries, providing end-to-end support from idea to patient.
Differentiator
Problem solved
Functional benefit
Brands
- QbD IVD | Qarad: Specialized in Regulatory Affairs and Quality Assurance for In Vitro Diagnostic Devices, CE Marking, Quality Systems, and Electronic Instructions for Use
- Quercus
- Scilife
- Simabs
- SciencePharma
- Rescop
- PrecisionDx (CDx)
Products and services
- Regulatory Affairs Comprehensive regulatory affairs services covering EU market entry, CE marking, FDA clearance, technical documentation, and submission packages for MDR and global markets, serving pharma, biotech, and medical device companies.
- Clinical Solutions Full-service clinical trial support for medical device manufacturers and pharma companies, from strategy and protocol development to site selection, monitoring, and regulatory support.
- Qualification & Validation Scalable, flexible support from facility commissioning to equipment qualification, including commissioning, facility, utility, and equipment qualification, process validation, cleaning validation, analytical method validation, sterilization validation, and tech transfer.
- Quality Assurance Implementation of FDA, EMA, FAHMP, and ISO standards (ISO 13485, ISO 14971), internal and external audits by certified lead auditors, and lifecycle management for Medical Device Software and digital health solutions.
- Software Solutions & Services IEC 62304 software lifecycle compliance, design and development support, SaMD classification, AI Act readiness, cybersecurity assessments, and DevOps integration with QMS for medical device software makers.
- Toxicology Toxicology services supporting pharmaceutical and life sciences companies with regulatory compliance and safety assessment.
- Lab Services Laboratory services provided through the Quercus GMP-certified contract laboratory serving pharmaceutical and life science industries, including cosmetics, herbal products, food supplements, and medical devices.
- Pharmacovigilance Pharmacovigilance services including vigilance reporting, risk management, and post-market surveillance for pharmaceutical products.
- Audits Global GxP, MDR, and IVDR audits executed by certified experts, including GMP, GDP, GCP, GLP, GVP, ISO 13485, supplier/vendor audits, mock inspections, and internal audits for Pharma, Biotech, and MedTech clients.
- Medical Device CRO Full-service clinical trial support for medical device manufacturers, from strategy and protocol development through post-market clinical follow-up.
- IVD CRO Clinical performance studies, biostatistics, and regulatory support tailored for IVD manufacturers, with 24 years of experience and 280+ clinical performance studies across 45+ analytes.
- PrecisionDx (Companion Diagnostics) Companion diagnostics services synchronizing Pharma and IVD workstreams, covering the entire CDx lifecycle including regulatory affairs strategy, performance studies, legal representation, and test site monitoring.
- Scilife Software as a Service (SaaS) quality management platform for Pharma, Biotech, and Medical Devices to efficiently manage quality, process, and product related activities in compliance with GxP, MDR, and IVDR regulations.
Quantifiable outcome
- 1200+ clients supported including startups, scale-ups, mid-sized companies, and industry leaders
- +6 more outcomes
Companies that use QbD Group
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles4 records
QbD Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
QbD Group partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core and minor.
- VigintakecorePartnership to drive digital transformation of pharmacovigilance through intelligent automation and innovative digital solutions, combining regulatory expertise, quality systems, and advanced technology.
- RescopcoreAcquired in May 2026 to expand Software Solutions & Services division and strengthen presence in Netherlands, Poland, Germany, Switzerland and US. Specialist in GxP compliance, computer system validation, and validation software for life sciences.
- delawarecoreStrengthened partnership to help life sciences companies accelerate digital transformation while ensuring full GxP compliance. Delaware is a global consultancy and SAP Platinum Partner.
- ASEBIOminorQbD Group joins ASEBIO, strengthening commitment to quality, compliance, and safety within the Spanish life sciences sector.
- QaradcoreAcquired by QbD Group in 2021 with intui's assistance. Specialized in Regulatory Affairs and Quality Assurance for In Vitro Diagnostic Devices. Now operating as QbD IVD | Qarad.
- QuercuscoreGMP certified contract laboratory serving pharmaceutical companies and other life science and health industries, including cosmetics, herbal products, food supplements and medical devices.
- ScilifecoreSaaS solution for Pharma, Biotech and Medical Devices to efficiently manage quality, process and product related activities according to compliance regulations.
- SimabscoreContract development and manufacturing organisation for monoclonal antibodies, delivering fast, flexible and cost-effective solutions through continuous bioprocessing.
- SciencePharmacorePolish consulting and importing services leader for the pharmaceutical industry, with 120 specialists and over 820 prepared dossiers for medicinal products since 2004.
- PILS (Partners in Life Sciences)minorPartnership between Flemish companies offering services and products in life sciences, improving the footprint of smaller companies towards big pharma.
- ISPEminorInternational Society for Pharmaceutical Engineering - world's largest non-profit serving regulatory advancement throughout the entire pharmaceutical lifecycle.
- Flanders.biominorNetworking organisation for life sciences sector in Flanders with 300+ members. QbD CEO Bart Van Acker is a board member.
- HollandBIOminorFast-growing interest group representing Dutch biotech industry, uniting stakeholders from start-ups to large companies.
- Pharma.beminorFederation of innovative biopharmaceutical industry in Belgium, representing over 130 companies and 35,000 employees.
- TOPRAminorProfessional membership organization for individuals working in healthcare regulatory affairs, promoting excellence across the regulatory profession.
- RAPSminorLargest global organization of professionals in regulatory and quality for healthcare products, home to the RAC credential recognizing regulatory excellence.
- HealixiaminorBelgian community of all professionals active along the lifecycle of medicines, medical devices, IVD and other health-related products.
- BioWinminorCompetitiveness cluster bringing together all innovation system players in health (biopharma and medtech) in Wallonia.
- BIVDAminorNational industry association for manufacturers and distributors of IVD products in the UK, representing more than 95% of the industry.
- EMWAminorEuropean Medical Writers Association - network of professionals representing, supporting, and training medical communicators.
- EAARminorEuropean Association of Authorised Representatives, established in 2002 to represent organizations providing EU Authorised Representative services for medical devices.
- BeCROminorProfessional association of Belgian Contract Research Organisations supporting clinical research and development of new pharmaceutical and medical device products.
Scale indicators15 records
Recent moves7 records
Expansion highlights6 records
QbD Group competitors and assessment
Company assessmentDirect peers
- Pharmalex: Pharmalex is a specialist regulatory affairs and quality compliance consulting firm serving pharma and biotech. It is the closest direct peer to QbD Group in regulatory services breadth, geographic reach across Europe/Asia, and target customer profile.
- RQM+: RQM+ is a medical device and IVD regulatory, quality, and clinical consulting firm. It directly overlaps with QbD's IVD/MDR practice (Qarad) and competes for the same mid-market medical device manufacturers seeking CE marking and FDA clearance support.
- Qserve Group: Qserve is a European regulatory and quality consulting firm specializing in medical devices and IVDs. It competes head-to-head with QbD's IVD/MDR services and shares the same notified body and EU regulatory expertise positioning.
- ProPharma Group: ProPharma Group provides regulatory compliance, quality, and pharmacovigilance consulting for pharma, biotech, and medical device companies. Direct overlap with QbD's regulatory affairs, QA, and pharmacovigilance service lines.
- NSF International (Health Sciences): NSF's Health Sciences division offers regulatory consulting, training, and quality services for medical devices, pharma, and IVDs. Comparable in service scope to QbD's regulatory and quality consulting practice, with similar reliance on technical training and certification.
- Veranex: Veranex is a medtech-focused CRO and regulatory consulting firm offering clinical, regulatory, and quality services for medical device companies. Directly comparable to QbD's medical device CRO and regulatory practice.
Broad incumbents
- ICON plc: ICON is one of the world's largest clinical CROs with broad regulatory and consulting capabilities across pharma and medical devices. A larger, broader incumbent that competes with QbD's clinical solutions practice but at much greater scale and breadth.
- IQVIA: IQVIA is the largest life sciences services platform globally, combining clinical research, regulatory consulting, technology, and data analytics. A broad incumbent whose regulatory and quality consulting practice overlaps with QbD's mid-market services.
Emerging players
- MasterControl: MasterControl provides SaaS quality management and regulatory compliance software for life sciences. Direct competitor to QbD's Scilife SaaS platform in the eQMS market, with greater scale and a longer independent track record.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
QbD Group social profiles
Digital presenceQbD Group compliance and trust
Trust signalCompliance4 records
QbD Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
QbD Group leadership team
Management profileNumber of profiles
Profiles13 records
QbD Group subsidiaries and ownership
Company hierarchySubsidiaries6 records
QbD Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QbD Group M&A and investment
M&A and investmentM&A7 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QbD Group
What does QbD Group do?
QbD Group is a life sciences consulting firm that delivers full-lifecycle support from idea to patient across Pharma, Biotech, Medical Devices, and IVD industries. The company sells professional services in Regulatory Affairs, Clinical Solutions, Qualification & Validation, Quality Assurance, Software Solutions & Services, Toxicology, Lab Services, Pharmacovigilance, Audits, and Companion Diagnostics, complemented by the Scilife SaaS quality management platform and the GMP-certified Quercus contract laboratory.
Is QbD Group a public or private company?
QbD Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was QbD Group founded?
QbD Group was founded in 2011. It employs 501 to 1,000 people.
Where is QbD Group based?
QbD Group is headquartered in Wilrijk, Belgium, in the Europe region.
How does QbD Group make money?
One revenue line is on record: professional Services.
Who are QbD Group's main competitors?
Direct peers on record are Pharmalex, RQM+, Qserve Group, ProPharma Group, NSF International (Health Sciences) and Veranex. Broad incumbents are ICON plc and IQVIA. MasterControl is listed as an emerging player.
Does QbD Group have an API?
No public API is recorded for QbD Group.
What industry is QbD Group in?
QbD Group's product category is Life Sciences Regulatory Consulting. Its primary akta.pro industry code is HLAGAKAB, CMC Regulatory Affairs (Modules 2/3, Variations, Post-Approval CMC), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 54161 and its SIC code is 8742.